-
@ Brian Appavu, MD
2025-02-13 20:04:22
I agree and have my own experience dealing with the issue of indirects that the public likely doesn't fully understand. Institutions may not like or want grants that don't offer high indirects, even if the funding opportunity is promising for the investigator. Sometimes, institutions may only approve the submission of a grant if investigators agree to lower the amount offered toward a clinicians' time to the research to 'offset the cost' of less available indirects. Other times, an increase in an institutions indirect requests may cause a research team to lose funds dedicated to them on an ongoing study. Very often, this occurs with the actual research team having no clarity regarding where the indirects are going. I think if we were to achieve decentralized fundraising for medical research, contributors and investors would have a strong demand to know exactly where there money goes, and that it helps the true cause of the research.
Fix the money, fix the world...